Skip to main content
Journal cover image

Clinical and Epidemiological Profile of Heart Failure Patients With Chagas Disease: Insights From the SEPE-HF Registry.

Publication ,  Journal Article
Giorgi, J; Cristodulo, R; Vaca, C; Ureña, D; Rejas, I; Rojas, J; Espinoza, F; Kaplinsky, E; Barbagelata, A
Published in: Am J Cardiol
August 18, 2025

Chagas cardiomyopathy (Ch-CMP) represents a unique and understudied phenotype of heart failure (HF) in endemic regions, with distinct clinical, electrocardiographic, and therapeutic characteristics compared to non-Chagas HF. In this retrospective cohort of 417 patients hospitalized for decompensated HF at a tertiary center in Brazil, 155 (37.1%) had confirmed Ch-CMP. Chagas patients were younger (mean age 67.5 vs 67.7 years, p = 0.86), had lower BMI (28.65 vs 25.40, p < 0.001), and a higher proportion of males (50.9% vs 47.7%, p = 0.56). Comorbidities were less frequent in the Chagas group, including hypertension (49.6% vs 70.1%, p = 0.001) and ischemic heart disease (3.2% vs 16.6%, p = 0.001). Electrocardiographic abnormalities were more prevalent among Chagas patients, such as right bundle branch block (17.6% vs 9%, p = 0.015), atrial fibrillation (37.9% vs 23%, p = 0.001), and pacemaker rhythms (22.2% vs 3.7%, p = 0.001). Systolic dysfunction (LVEF < 40%) was more common in Chagas (59.4% vs 27.1%, p = 0.001). Despite these differences, cardiovascular inhospital mortality did not significantly differ (8.4% vs 5.2%, p = 0.279). The use of guideline-directed medical therapy at discharge was suboptimal in both groups, but even lower in Chagas patients, particularly for beta-blockers (52% vs 64%, p = 0.02) and ACEi/ARB/ARNi (54% vs 68%, p = 0.01). Loop diuretics were used in only 64% of the entire cohort; among those not requiring diuretics, arrhythmias and infections were the leading causes of admission, atrial fibrillation in 22 patients, and infection in 21. In conclusion, Chagas cardiomyopathy remains a major contributor to HF hospitalizations in endemic regions, with a unique arrhythmogenic and vasodilated profile, lower prevalence of traditional risk factors, and concerning therapeutic gaps at discharge that merit targeted intervention.

Duke Scholars

Published In

Am J Cardiol

DOI

EISSN

1879-1913

Publication Date

August 18, 2025

Volume

255

Start / End Page

126 / 133

Location

United States

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Giorgi, J., Cristodulo, R., Vaca, C., Ureña, D., Rejas, I., Rojas, J., … Barbagelata, A. (2025). Clinical and Epidemiological Profile of Heart Failure Patients With Chagas Disease: Insights From the SEPE-HF Registry. Am J Cardiol, 255, 126–133. https://doi.org/10.1016/j.amjcard.2025.08.024
Giorgi, Juliana, Roberto Cristodulo, Carlos Vaca, Daniela Ureña, Isabel Rejas, Jimena Rojas, Fabricio Espinoza, Edgardo Kaplinsky, and Alejandro Barbagelata. “Clinical and Epidemiological Profile of Heart Failure Patients With Chagas Disease: Insights From the SEPE-HF Registry.Am J Cardiol 255 (August 18, 2025): 126–33. https://doi.org/10.1016/j.amjcard.2025.08.024.
Giorgi J, Cristodulo R, Vaca C, Ureña D, Rejas I, Rojas J, et al. Clinical and Epidemiological Profile of Heart Failure Patients With Chagas Disease: Insights From the SEPE-HF Registry. Am J Cardiol. 2025 Aug 18;255:126–33.
Giorgi, Juliana, et al. “Clinical and Epidemiological Profile of Heart Failure Patients With Chagas Disease: Insights From the SEPE-HF Registry.Am J Cardiol, vol. 255, Aug. 2025, pp. 126–33. Pubmed, doi:10.1016/j.amjcard.2025.08.024.
Giorgi J, Cristodulo R, Vaca C, Ureña D, Rejas I, Rojas J, Espinoza F, Kaplinsky E, Barbagelata A. Clinical and Epidemiological Profile of Heart Failure Patients With Chagas Disease: Insights From the SEPE-HF Registry. Am J Cardiol. 2025 Aug 18;255:126–133.
Journal cover image

Published In

Am J Cardiol

DOI

EISSN

1879-1913

Publication Date

August 18, 2025

Volume

255

Start / End Page

126 / 133

Location

United States

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
  • 1102 Cardiorespiratory Medicine and Haematology